Related Experiment Video
Updated: Jul 12, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Déjà vu! A Case of Recurrent Metabolic Dysfunction-Associated Steatohepatitis 70 Days After Liver Transplantation
Matthew Still1, April Gettelfinger1, Victor Akinditan1
1College of Medicine, University of Cincinnati, Cincinnati, OH.
None:
Metabolic dysfunction-associated steatohepatitis (MASH) recurrence following liver transplantation occurs in 11%-24% of recipients, typically months to years posttransplant. Early recurrence (<6 months) is extremely rare. We present a 40-year-old woman with obesity and remote kidney transplant who underwent liver transplantation for MASH cirrhosis. At 10 weeks posttransplant, she developed acute cellular rejection and 68% steatosis, progressing to >95% steatohepatitis with F1 fibrosis within 6 days on corticosteroid treatment. Multimodal intervention, including semaglutide, resulted in histologic improvement (steatosis reduced to 30%, ballooning resolved) with sustained biochemical normalization. This case highlights ultra-rapid MASH recurrence and favorable histological response to early multimodal metabolic intervention.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatic Encephalopathy